ANKRD2 expression combined with TNFRSF19 expression for evaluating the prognosis of oral squamous cell carcinoma patients

ANKRD2 expression combined with TNFRSF19 expression for evaluating the prognosis of oral squamous cell carcinoma patients

Objective: As an important chemotherapy drug, cisplatin has been widely used in the treatment of many cancers. However, many patients, including oral squamous cell carcinoma (OSCC) patients, experience unacceptable outcomes from cisplatin treatment. Thus, we devised a risk model for predicting the s...

Full description

Bibliographic Details
Main Authors: Shucong Yao, Hongwei Xiao, Changji Wei, Shisheng Chen
Format: Article
Language:English
Published: Elsevier 2024-01-01
Series:Heliyon
Subjects:
ANKRD2
TNFRSF19
Cisplatin sensitivity
Oral squamous cell carcinoma (OSCC)
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024001221

Internet

http://www.sciencedirect.com/science/article/pii/S2405844024001221

Similar Items